Prognostic Siginificance of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Limited Stage Small Cell Lung Cancer

Prognostic Siginificance of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Limited Stage Small Cell Lung Cancer - Prognostic Siginificance of FDG-PET in Patients with Limited Stage Small Cell Lung Cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004385

Enrollment

Registered

2010-10-14

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limited Stage Small Cell Lung Cancer

Interventions

CDDP+VP-16 4 cycles CDDP 80mg/m2 day1, VP-16 100mg/m2 day1-3 early concurrent twice-daily RT 1.5Gy 30fraction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) cytologically, histologically proven small-cell lung cancer 2) limited disease except c-stage I 3) age 20-74 years old 4) performance status of 0-1 5) measurable disease 6) no prior treatment for small-cell lung cancer 7) no history of chemotherapy 8) adequate organ functions 9) written informed consent

Exclusion criteria

Exclusion criteria: 1) pericardial effusion 2) active concomitant malignancy 3) pregnant or lactating women 4) interstitial pneumonia/active lung fibrosis on chest x-ray, watery diarrhea, intestinal obstruction or paralysis, uncontrolled heart disease or a history of myocardial infarction within the previous 6 months, uncontrolled diabetes mellitus, active infection, psychological disease deemed unacceptable for inclusion to the study, long-term steroid treatment.

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Progression free survival Response rate	—

Countries

Japan

Contacts

Public ContactNoriyuki Ebi

Iizuka Hospital Department of respiratory medicine

0948-22-3800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026